Justor Banda, T. Bulaya, A. Mweemba, M. Mweene, N. Suwilanji, C. Natasha, S. Siziya
{"title":"Early mortality in patients with kidney failure starting chronic dialysis in Zambia: A retrospective cohort analysis","authors":"Justor Banda, T. Bulaya, A. Mweemba, M. Mweene, N. Suwilanji, C. Natasha, S. Siziya","doi":"10.21804/25-1-4733","DOIUrl":null,"url":null,"abstract":"Introduction: Dialysis is the primary kidney replacement therapy for patients with kidney failure in sub-Saharan Africa. We assessed the rates and predictors of early mortality in Zambian patients starting chronic dialysis. Methods: This retrospective study included all patients who started chronic haemodialysis (HD) or peritonealdialysis (PD) between 1 January 2017 and 31 August 2020 at the three largest public dialysis centres in Zambia. Data on clinical, laboratory and dialysis characteristics were extracted from medical records. The primary outcome of interest was the mortality rate at 90 days. Results: A total of 154 patients were included in the study; 43.5% were female and 32% were 50 years or older.The main causes of kidney failure were hypertension (59%), glomerulonephritis (10%), HIV/AIDS (10%) andunknown (8%). The mortality rate at 90 days was 12.3%. Of these, 42% were cardiovascular-related mortalities and 32% died of infection related to central venous catheters. The lymphocyte percentage of total white blood cells was lower in patients who died compared to survivors (12.7 vs 20.8%) and was an independent predictor of early mortality (OR 0.914, 95% CI 0.850–0.983; P = 0.015). Conclusions: Early mortality was high in Zambian patients starting dialysis, and a low lymphocyte percentage was a predictor of mortality.","PeriodicalId":32934,"journal":{"name":"African Journal of Nephrology","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"African Journal of Nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21804/25-1-4733","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
Introduction: Dialysis is the primary kidney replacement therapy for patients with kidney failure in sub-Saharan Africa. We assessed the rates and predictors of early mortality in Zambian patients starting chronic dialysis. Methods: This retrospective study included all patients who started chronic haemodialysis (HD) or peritonealdialysis (PD) between 1 January 2017 and 31 August 2020 at the three largest public dialysis centres in Zambia. Data on clinical, laboratory and dialysis characteristics were extracted from medical records. The primary outcome of interest was the mortality rate at 90 days. Results: A total of 154 patients were included in the study; 43.5% were female and 32% were 50 years or older.The main causes of kidney failure were hypertension (59%), glomerulonephritis (10%), HIV/AIDS (10%) andunknown (8%). The mortality rate at 90 days was 12.3%. Of these, 42% were cardiovascular-related mortalities and 32% died of infection related to central venous catheters. The lymphocyte percentage of total white blood cells was lower in patients who died compared to survivors (12.7 vs 20.8%) and was an independent predictor of early mortality (OR 0.914, 95% CI 0.850–0.983; P = 0.015). Conclusions: Early mortality was high in Zambian patients starting dialysis, and a low lymphocyte percentage was a predictor of mortality.
导读:透析是撒哈拉以南非洲肾衰竭患者的主要肾脏替代疗法。我们评估了开始慢性透析的赞比亚患者的早期死亡率和预测因素。方法:本回顾性研究纳入了2017年1月1日至2020年8月31日在赞比亚三个最大的公共透析中心开始慢性血液透析(HD)或腹膜透析(PD)的所有患者。从医疗记录中提取临床、实验室和透析特征数据。主要观察指标为90天死亡率。结果:共纳入154例患者;43.5%为女性,32%为50岁或以上。肾衰竭的主要原因是高血压(59%)、肾小球肾炎(10%)、HIV/AIDS(10%)和未知(8%)。90天死亡率为12.3%。其中,42%是心血管相关死亡,32%死于中心静脉导管相关感染。与幸存者相比,死亡患者的淋巴细胞占总白细胞的比例较低(12.7% vs 20.8%),并且是早期死亡率的独立预测因子(OR 0.914, 95% CI 0.850-0.983;P = 0.015)。结论:赞比亚开始透析的患者早期死亡率很高,低淋巴细胞百分比是死亡率的预测因子。